Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
Covington
US Army
Argus Health
McKinsey
Farmers Insurance
Federal Trade Commission
US Department of Justice

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,754,108

« Back to Dashboard

Which drugs does patent 8,754,108 protect, and when does it expire?

Patent 8,754,108 protects PROTONIX IV and is included in one NDA.

Protection for PROTONIX IV has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty-five patent family members in forty countries.
Summary for Patent: 8,754,108
Title:Freeze-dried pantoprazole preparation and pantoprazole injection
Abstract: Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium hydroxide and/or sodium carbonate are disclosed. The preparations have advantageous properties when reconstituted for injection.
Inventor(s): Linder; Rudolf (Constance, DE), Dietrich; Rango (Constance, DE)
Assignee: Takeda, GmbH (Constance, DE)
Application Number:12/010,124
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Drugs Protected by US Patent 8,754,108

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Wyeth Pharms Inc PROTONIX IV pantoprazole sodium INJECTABLE;IV (INFUSION) 020988-001 Mar 22, 2001 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,754,108

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
00125569Nov 22, 2000

Non-Orange Book US Patents Family Members for Patent 8,754,108

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,780,881 Freeze-dried pantoprazole preparation and pantoprazole injection ➤ Try a Free Trial
7,351,723 Freeze-dried pantoprazole preparation and pantoprazole injection ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 8,754,108

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 034277 ➤ Try a Free Trial
Argentina 092374 ➤ Try a Free Trial
Austria 381946 ➤ Try a Free Trial
Australia 1604202 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Citi
Baxter
Boehringer Ingelheim
AstraZeneca
Queensland Health
McKinsey
QuintilesIMS
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.